• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG ENDURO MENISCAL COMPONENT F2 12MM; KNEE ENDOPROSTHETICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG ENDURO MENISCAL COMPONENT F2 12MM; KNEE ENDOPROSTHETICS Back to Search Results
Model Number NR881M
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Failure of Implant (1924)
Event Date 09/29/2021
Event Type  Injury  
Manufacturer Narrative
Manufacturing site evaluation: investigation on-going.Additional information / investigation results will be provided in a supplemental report.
 
Event Description
It was reported that there was an issue with nr881m - enduro meniscal component f2 12mm.According to the complaint description, there was a revision surgery 8 months post surgery to change the femur implant.A revision surgery was necessary.Additional patient information is not available.The adverse event is filed under aag reference (b)(4).Involved components: nr293k - femur extens.Stem 6° d18x77mm cemented - lot 52624669.Nb012k - enduro tibial comp.Offset cemented t2 - lot 52647195.Nx043 - patella 3-pegs p3 - lot 52624197.Nb015k - enduro femoral component cemented f2l - lot 52637143.Nr400k - nut f/femur extens.Stem all sizes neutr.- lot 52627686.Nr195k - tibia offset stem d15x92mm cemented - lot 52640922.
 
Event Description
Update: a distal femur replacement was performed in september 2021.During the surgery, the meniscal component was changed.And it was noted that the removed rotation axis could not be moved in the bearing for the rotation axis.The rotation axis and bearing were available for investigation.
 
Manufacturer Narrative
Investigation: visual inspection: the provided explants were in a decontaminated condition.Only 2 components were provided.In its incoming condition, the bearing for the rotation axis was still fixed on the rotation axis.With a little effort, it was possible to remove and separate them.The surface of the rotation axis shows all the way around visible residues.These residues were analyzed in our internal aag laboratory.The analysis results showed approximately 91 % agreement with dry blood.The case was also discussed with several specialists from the product management and development department.Batch history review: the device quality and manufacturing hisotry records (dhr) have been checked for all leading device(s) lot numbers and the products found to be according to our specifiaction valid at the time of production.There are no similar complaints aginst the same lot number(s) with this error pattern.The review of risk assessment revealed that the overall risk level (severity 4(5) x probability of occurrence 2(5)) according to din en iso 14971 is still acceptable.In this case the product risk analysis is only conditionally applicable because the root cause for the mentioned problems remains unclear.Furthermore, the mentioned sluggishness of this 2 parts cannot be evaluated as an error per se.Explanation and rationale: on the basis of the current information, a clear conclusion cannot be drawn.The device history records have been checked and no abnormalities could be observed.As mentioned above, this case was discussed with several specialists from the product management and development department.The root cause for the revision operation (2021-09-29) was the circumstance that the femur fracture which was treated with plate and cercelages (2021-06 / rev.1) failed.In the course of this, the meniscal component was changed -> thereby it was notice that the explanted rotation axis could only be moved with difficultly in the bearing for the rotation axis.After consultation with specialists from the product management and development department it can be assumed that the sluggishness between the two components was caused due to the residues on the surface of the rotation axis.How these residues got between the rotation axis and the bearing remains unclear.A possible root cause for this could be that due to the temporary immobility of the patient, these residues (blood, body fluids) got between the rotation axis and the bearing.But this is only speculative.In the implanted state under normal conditions (movement), the mentioned sluggishness of this two parts would hardly have been noticed and thus would not have been recognized as a defect.Without further information the root cause for the mentioned periprosthetic distal femur fracture and the subsequent failure of the plate and cercelage treatment also remains unclear.A possible root cause for this could be that the used enduro system is the wrong therapy for this patient.This is also speculative.It cannot be assumed that the used implants are causal for the mentioned problems.The mentioned circumstances/difficulties are rather patient-related/usage-related.Conclusion: due to the current deviation and according to the explanation and rationale, the root cause of the problem is most probably patient and usage-related.Corrective action: based upon the investigations results a capa is not necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURO MENISCAL COMPONENT F2 12MM
Type of Device
KNEE ENDOPROSTHETICS
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
Manufacturer (Section G)
AESCULAP AG
po box 40
tuttlingen, 78501
GM   78501
Manufacturer Contact
christian von der grün
po box 40
tuttlingen, 78501
GM   78501
MDR Report Key12673882
MDR Text Key277686689
Report Number9610612-2021-00673
Device Sequence Number1
Product Code KRO
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K101815
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/21/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNR881M
Device Catalogue NumberNR881M
Device Lot Number52622630
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/05/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/02/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/08/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NB012K - LOT 52647195; NB015K - LOT 52637143; NR195K - LOT 52640922; NR293K - LOT 52624669; NR400K - LOT 52627686; NX043 - LOT 52624197; NB012K - LOT 52647195; NB015K - LOT 52637143; NR195K - LOT 52640922; NR293K - LOT 52624669; NR400K - LOT 52627686; NX043 - LOT 52624197
Patient Outcome(s) Required Intervention;
Patient Age56 YR
-
-